Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) decrease life expectancy for affected patients. The aim was to describe the perceptions of received information regarding diagnosis, treatment and management, as well as social support and coping perceived by patients with PAH or CTEPH. Methods: A descriptive, national cohort survey that included patients from all PAH-centres in Sweden. A quantitative methodology was employed where all patients received three questionnaires, QLQ-INFO25, Mastery Scale and Social Network & Support Scale. Results: The response rate was 74% (n. =325), mean age 66. ±. 14. years, 71% were female and 69% were diagnosed with PAH and 31% with CTEPH. Sixty perce...
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especiall...
BACKGROUND: The Spanish "Registry of Pulmonary Arterial Hypertension" (REHAP), started in 2007, incl...
Background: Pulmonary hypertension (PH) is a heterogeneous, debilitating condition with highly relev...
Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (...
Objectives: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are se...
Objectives: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are se...
Copyright © 2014 Bodil Ivarsson et al. This is an open access article distributed under the Creative...
Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) shar...
Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive disease. Altho...
As pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) a...
<p><b>Objectives:</b> The Swedish Pulmonary Arterial Hypertension Register (SPAHR) is an open contin...
Pulmonary arterial hypertension (PAH) is a debilitating disease that pervades all aspects of a patie...
Background: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Abstract Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonar...
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especiall...
BACKGROUND: The Spanish "Registry of Pulmonary Arterial Hypertension" (REHAP), started in 2007, incl...
Background: Pulmonary hypertension (PH) is a heterogeneous, debilitating condition with highly relev...
Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (...
Objectives: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are se...
Objectives: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are se...
Copyright © 2014 Bodil Ivarsson et al. This is an open access article distributed under the Creative...
Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) shar...
Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive disease. Altho...
As pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) a...
<p><b>Objectives:</b> The Swedish Pulmonary Arterial Hypertension Register (SPAHR) is an open contin...
Pulmonary arterial hypertension (PAH) is a debilitating disease that pervades all aspects of a patie...
Background: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Abstract Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonar...
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especiall...
BACKGROUND: The Spanish "Registry of Pulmonary Arterial Hypertension" (REHAP), started in 2007, incl...
Background: Pulmonary hypertension (PH) is a heterogeneous, debilitating condition with highly relev...